v3.24.1.1.u2
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
CURRENT ASSETS    
Cash $ 3,770,229 $ 96,391
Prepaid expenses 220,930
Due from Chromocell Corporation 40,400
TOTAL CURRENT ASSETS 4,031,559 96,391
TOTAL ASSETS 4,031,559 96,391
CURRENT LIABILITIES    
Accounts payable and accrued expenses 2,407,515 4,620,925
Accrued compensation 493,924 645,947
Bridge loan, net of debt discount 316,324
Loan payable, net of debt discount 202,279
Loan payable - related party, net of debt discount 750,082
Due to Chromocell Corporation 5,386
TOTAL CURRENT LIABILITIES 2,901,439 6,540,943
TOTAL LIABILITIES 2,901,439 6,540,943
STOCKHOLDERS’ EQUITY (DEFICIT)    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 5,766,704 and 3,914,338 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 578 391
Additional paid in capital 17,211,521 7,074,646
Accumulated deficit (16,081,979) (13,519,649)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) 1,130,120 (6,444,552)
TOTAL LIABILITIES, AND STOCKHOLDERS’ EQUITY (DEFICIT) 4,031,559 96,391
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY (DEFICIT)    
Preferred stock, value, issued 60
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) 60
Series C Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY (DEFICIT)    
Preferred stock, value, issued
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) $ 1

Source

HTML PDF
ZIP